Farallon Capital Management’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
|
|||||
|
2025
Q1 | $658K | Hold |
|
|||||
|
2024
Q4 | $794K | Sell |
|
|||||
|
2024
Q3 | $479K | Hold |
|
|||||
|
2024
Q2 | $402K | Hold |
|
|||||
|
2024
Q1 | $1.42M | Hold |
|
|||||
|
2023
Q4 | $1.16M | Sell |
|
|||||
|
2023
Q3 | $2.8M | Hold |
|
|||||
|
2023
Q2 | $4.72M | Sell |
|
|||||
|
2023
Q1 | $9.8M | Sell |
|
|||||
|
2022
Q4 | $22.3M | Sell |
|
|||||
|
2022
Q3 | $23.4M | Hold |
|
|||||
|
2022
Q2 | $22.8M | Hold |
|
|||||
|
2022
Q1 | $30.4M | Buy |
|
|||||
|
2021
Q4 | $24.4M | Hold |
|
|||||
|
2021
Q3 | $30.9M | Hold |
|
|||||
|
2021
Q2 | $28.5M | Sell |
|
|||||
|
2021
Q1 | $53.5M | Hold |
|
|||||
|
2020
Q4 | $37.3M | Buy |
|
|||||
|
2020
Q3 | $28.6M | Sell |
|
|||||
|
2020
Q2 | $39.3M | Hold |
|
|||||
|
2020
Q1 | $30.4M | Hold |
|
|||||
|
2019
Q4 | $37.1M | Buy |
|
|||||
|
2019
Q3 | $39.3M | Buy |
|
|||||
|
2019
Q2 | $20.5M | Buy |
|